Authors
Latest:
Pharmacotherapy Timing in Heart Failure and Impact on Healthcare CostsThe findings of a retrospective study suggest that timing of heart failure (HF)-related pharmacotherapy following a HF-related encounter has potential implications on subsequent healthcare costs.
Latest:
Understand the 2025-2026 Flu Vaccine Composition RecommendationsThe only major change is in the included strain of influenza A/H2N2 virus, which has been updated for both the egg-based and the cell- and recombinant-based vaccines.
Latest:
The Beauty of Vitamin A and Drug SpinoffsThe best natural and dietary supplements get turned into drugs. This is what happened to Vitamin A.
Latest:
Study Examines Impact of Alcohol on Health, Drug Interactions in Older WomenFive risk factors increased the likelihood of problematic alcohol consumption in older women.
Latest:
Basal Insulin Therapy in Type 2 Diabetes Management: What the Pharmacist Should KnowGuidance on the use of basal insulins (BI) and insulin pens to enable pharmacists to answer questions regarding the safe and effective use of BI for the management of diabetes.
Latest:
How Old Is Old? Rethinking the “Normal” Process of AgingConventional wisdom on growing old is getting a second look.
Latest:
Pharmacists as Providers: The Road to Recognition in Washington StateNational attention in the pharmacy press has focused recently on pharmacists being recognized as providers under federal health programs such as the Medication Modernization Act.
Latest:
Moving Health Care into the Future: Proposal for Pharmacist-led Refill AuthorizationsPharmacist-led refill authorizations are a practical solution to the nation’s health care crisis, helping to improve quality while reducing costs as well as saving physicians’ time.
Latest:
Renal Cell Carcinoma is Treatable and CurableEarly diagnosis, surgery while cancer is confined to kidney are key, but pharmacological agents are used for Stage IV.
Latest:
Easing the Minds of Parents 1 EpiPen at a TimeAllowing school access to epinephrine injectors improves patient care.
Latest:
Immune Checkpoint Inhibitor-Associated Nephritis: A Case of Nivolumab-Induced Acute Kidney Injury in a Patient with Urothelial CarcinomaThis case highlights the importance of recognizing ICPI-AKI, implementing effective therapeutic interventions, and understanding the clinical context to prevent irreversible renal damage.
Latest:
The Appropriateness of Use of 3 Classes of Psychotropic Medications in Children and AdolescentsFor the majority of children and adolescents receiving a psychotropic medication there is a valid medical diagnosis.
Latest:
Cost-Effectiveness of Fingolimod in Treating Patients With Relapsing-Remitting Multiple SclerosisFingolimod, a first-line, once-daily oral disease-modifying therapy for relapsing-remitting multiple sclerosis, has the lowest cost per relapse avoided compared with other first-line agents.
Latest:
Transformative Leadership Can and Should be Practiced by Everyone in the Pharmacy OrganizationA transformational leader can make the difference between an efficient, profitable organization and one that is mired in mediocrity.
Latest:
Rx for Medicare Transparency, Ending Retroactive Pharmacy ClawbacksImproved transparency is needed to prevent clawback fees.
Latest:
What Patients Should Know About Generic Drugs: A Resource Guide for PharmacistsA wealth of resource is available to help pharmacists build public trust in the quality and efficacy of generic medications.
Latest:
E-Prescribing With Decision Support Is Associated With Improvements in Medication AdherenceThis study evaluates whether provider adoption and use of formulary decision support for e-prescribing are directly associated with significant prescriber and patient behavior change.
Latest:
Impact of Generic Drug Discount Programs on Managed Care OrganizationsGeneric drug discount programs, which differ across large chain pharmacies, may result in significant savings for managed care organizations.
Latest:
Cost-Effectiveness of Rasagiline Compared With First-Line Early Parkinson Disease TherapiesExamination of the cost-effectiveness of rasagiline versus other approved first-line Parkinson disease therapies indicated that rasagiline was either cost saving or cost-effective in all cases.
Latest:
Impact of Co-Payment Discounts on Antidepressant Medication Adherence and CostsA unique co-payment discount program for antidepressants was associated with higher antidepressant medication adherence, lower likelihood of discontinuation, and lower healthcare costs.
